CCNY was identified as a candidate risk gene in IBD in several genome-wide association studies [3,4,5,6,7], and it has been suggested that candidate genes should be prioritized for functional studies, such as the current one [6]. This evidence concerns the gene CCNY and inflammatory bowel disease.